Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More
3 minute read

Gain Therapeutics Highlights Presentation Of Preclinical Data Demonstrating Potential Disease Modifying Benefits Of Its Novel Brain Penetrant Small Molecule Candidate GT-02287 In Two Preclinical Models Of Parkinson’s Disease

By Bill Haddad
Today, 2:29 PM
Treatment with GT-02287 Resulted in a Significant Dose-Dependent Improvement of Cellular Lysosomal Health and Fine Motor Skills   Results Presented at the International Congress of Parkinson's Disease and

GANX

Read More
6 minute read

Aggregate Insider Buying Remains Elevated For A Third Week $AMH

By Asif Suria
Today, 2:29 PM
In another challenging week for the markets where the Nasdaq dropped nearly 4%, insiders once again significantly stepped up their insider purchases for a third week in a row. We saw an increase across all three dimensions, number of unique insiders buying shares, the number of companies with insider buying and the absolute dollar amount of purchases.

ABNB